| Catalog | name | Description | price |
|---|---|---|---|
| R-M2-9960 | TAT-PEG2k-R6 | TAT-PEG2k-R6/TAT(YGRKKRRQRRR)-PEG2k-R6/R6(6Arginine)-PEG2k-TAT(YGRKKRRQRRR)/R6-PEG2k-TAT(YGRKKRRQRRR)/TAT-PEG2000-6Arginine is a dual cell-penetrating peptide conjugate in which the TAT sequence (YGRKKRRQRRR) is linked via a PEG2000 spacer to a hexarginine (R₆) peptide. Applications: Nanoparticle and liposome surface modification for enhanced cellular uptake; Intracellular delivery of drugs, siRNA, or proteins; Dual CPP (cell-penetrating peptide) system for improved endosomal escape and transport efficiency; Targeted delivery in gene or protein-based therapeutics. | price> |
| R-M2-9961 | TAT-PEG2000-carboxymethyl chitosan | TAT-PEG2000-carboxymethyl chitosan/TAT(YGRKKRRQRRR)-PEG2000-carboxymethyl chitosan/Carboxymethyl chitosan-PEG2000-TAT(YGRKKRRQRRR) is a cell-penetrating, biocompatible polymer conjugate combining the TAT peptide (YGRKKRRQRRR), PEG2000 spacer, and carboxymethyl chitosan (CMC) backbone. Applications: Gene and drug delivery systems (especially for siRNA or DNA); Cell-penetrating nanocarriers with improved biostability; Targeted intracellular transport for therapeutics or imaging probes; Smart polymer systems responsive to pH and cellular environments. | price> |
| R-M1-8337 | Fmoc-NH-PEG11-CH2COOH | Fmoc-NH-PEG11-CH2COOH is a PEG linker containing an Fmoc-protected amine and a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. Reagent grade, for research purpose. | price> |
| R-M1-8338 | Fmoc-NH-PEG12-CH2COOH,cas:2291257-76-4 | Fmoc-NH-PEG12-CH2COOH is a PEG linker containing an Fmoc-protected amine and a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. Reagent grade, for research purpose. | price> |
| R-M1-8342 | mPEG2K-TK-CRHSQMTVTSRL | The mPEG2000-TK-CP05 modified exosomes can serve as effective delivery platforms for enhanced photodynamic/chemical cancer treatment.CP05 peptide (CRHSQMTVTSRL) can be used to study injectable thermosensitive hydrogel for bone regeneration. | price> |
| R-M2-9978 | CRVLRSGSC(CC Looping)-peg-Chol | CRVLRSGSC-(CC Looping)-PEG-Chol/Cholesterol-peg-CRVLRSGSC(CC Looping) is a targeted amphiphilic conjugate composed of a cyclic peptide (CRVLRSGSC) linked via a polyethylene glycol (PEG) spacer to cholesterol (Chol). The CRVLRSGSC peptide contains two cysteine residues that form an intramolecular disulfide bond (CC looping), stabilizing its cyclic structure for enhanced receptor selectivity and proteolytic resistance. The PEG linker provides solubility and flexibility, while cholesterol serves as a lipophilic anchor for membrane or liposome incorporation. Applications: Targeted liposome or nanoparticle design: Enhances binding to specific receptors associated with the CRVLRSGSC motif; Drug delivery: Facilitates receptor-mediated uptake into specific tissues or cells; Membrane functionalization: Used to decorate lipid bilayers with targeting ligands; Theranostic systems: For coupling targeting peptides with imaging or therapeutic nanocarriers. | price> |
| R-M2-9979 | CRVLRSGSC(CC Looping)-peg-DMG | CRVLRSGSC-(CC Looping)-PEG–DMG is a cyclic peptide conjugate designed for targeted liposomal or nanoparticle applications. Applications: Targeted liposome or nanoparticle functionalization for enhanced cellular uptake; Receptor-mediated delivery systems (depending on CRVLRSGSC target specificity); Drug and gene delivery vectors with improved targeting and circulation profiles; Surface modification of lipid-based nanocarriers to impart targeting ability. | price> |
| R-M2-9981 | DMG-GfPRGFPAGG-PEG2000 | DMG-GfPRGFPAGG–PEG2000 is a peptide peg conjugate. Applications: Targeted liposomal or nanoparticle drug delivery: Enhances cellular uptake via integrin-mediated endocytosis. Functionalization of lipid bilayers: Provides specific bio-recognition sites on nanoparticle surfaces. Theranostic systems: Combines targeting with imaging or therapeutic payloads. Cell adhesion and tissue targeting studies: Useful in integrin-mediated binding assays. | price> |
| R-M2-9982 | Chol-GfPRGFPAGG-PEG2000 | Chol-GfPRGFPAGG-PEG2000/Cholesterol-GfPRGFPAGG-PEG2000 is a cholesterol–polyethylene glycol–peptide conjugate designed as a multifunctional amphiphilic molecule that can be incorporated into lipid-based or polymeric nanocarriers for targeted drug delivery or diagnostic applications. | price> |
| R-M1-8349 | NHS-PEG5K-cRGDfK | NHS-PEG5K-cRGDfK is a derivative of peptide peg. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


